Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.
- DOI
- 10.1200/go-25-00705
- Published
- 2026 May
- Container
- JCO global oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/go-25-00705,
title = {Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.},
author = {Peres Moreira RJ and Bines J and Dhungana A and Freeman JQ and Saha P and Sullivan ME and Yao K and Flores EM and Huo D and Pearson AT and Small IA and Olopade OI and Howard FM},
year = {2026},
journal = {JCO global oncology},
doi = {10.1200/go-25-00705},
url = {https://doi.org/10.1200/go-25-00705}
}RIS
TY - JOUR TI - Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings. AU - Peres Moreira RJ AU - Bines J AU - Dhungana A AU - Freeman JQ AU - Saha P AU - Sullivan ME AU - Yao K AU - Flores EM AU - Huo D AU - Pearson AT AU - Small IA AU - Olopade OI AU - Howard FM PY - 2026 JO - JCO global oncology DO - 10.1200/go-25-00705 UR - https://doi.org/10.1200/go-25-00705 ER -
APA
RJ, P. M., J, B., A, D., JQ, F., P, S., ME, S., K, Y., EM, F., D, H., AT, P., IA, S., OI, O., & FM, H. (2026). Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.. JCO global oncology. https://doi.org/10.1200/go-25-00705
Source records
- pubmed · retrieved 2026-09-25T21:38:21.705Z